Cargando…
Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction
TANK-binding kinase 1 (TBK1) regulates the interferon regulatory factor (IRF) 3 and IRF7 activation pathways by double strand RNA (dsRNA) via Toll-like receptor (TLR) 3 and by lipopolysaccharide (LPS) via TLR4. Rebamipide is useful for treating inflammatory bowel disease (IBD). Although IBD is assoc...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045689/ https://www.ncbi.nlm.nih.gov/pubmed/21373269 http://dx.doi.org/10.3164/jcbn.10-69 |
_version_ | 1782198863568830464 |
---|---|
author | Ogasawara, Naotaka Sasaki, Makoto Itoh, Yukimi Tokudome, Kentaro Kondo, Yoshihiro Ito, Yoshitsugi Tanida, Satoshi Kamiya, Takeshi Kataoka, Hiromi Joh, Takashi Kasugai, Kunio |
author_facet | Ogasawara, Naotaka Sasaki, Makoto Itoh, Yukimi Tokudome, Kentaro Kondo, Yoshihiro Ito, Yoshitsugi Tanida, Satoshi Kamiya, Takeshi Kataoka, Hiromi Joh, Takashi Kasugai, Kunio |
author_sort | Ogasawara, Naotaka |
collection | PubMed |
description | TANK-binding kinase 1 (TBK1) regulates the interferon regulatory factor (IRF) 3 and IRF7 activation pathways by double strand RNA (dsRNA) via Toll-like receptor (TLR) 3 and by lipopolysaccharide (LPS) via TLR4. Rebamipide is useful for treating inflammatory bowel disease (IBD). Although IBD is associated with nuclear factor-κB (NF-κB), any association with the TBK1-IRF pathway remains unknown. How rebamipide affects the TBK1-IRF pathway is also unclear. We analyzed the relationship between IBD (particularly ulcerative colitis; UC) and the TLR-TBK1-IRF3/7 pathway using human colon tissue, a murine model of colitis and human colonic epithelial cells. Inflamed colonic mucosa over-expressed TKB1, NAP1, IRF3, and IRF7 mRNA compared with normal mucosa. TBK1 was mainly expressed in inflammatory epithelial cells of UC patients. The expression of TBK1, IRF3, IRF7, IFN-α and IFN-β mRNA was suppressed in mice given oral dextran sulfate-sodium (DSS) and daily rectal rebamipide compared with mice given only DSS. Rebamipide reduced the expression of TBK1, IRF3 and IRF7 mRNA induced by LPS/dsRNA, but not of NF-κB mRNA in colonic epithelial cells. Rebamipide might suppress the TLR-TBK1 pathway, resulting in IRF3/7-induction of IFN-α/β and inflammatory factors. TBK1 is important in the induction of inflammation in patients with UC. If rebamipide represses the TLR-TBK1 pathway, then rectal administration should suppress inflammation of the colonic mucosa in patients with UC. |
format | Text |
id | pubmed-3045689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | the Society for Free Radical Research Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-30456892011-03-04 Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction Ogasawara, Naotaka Sasaki, Makoto Itoh, Yukimi Tokudome, Kentaro Kondo, Yoshihiro Ito, Yoshitsugi Tanida, Satoshi Kamiya, Takeshi Kataoka, Hiromi Joh, Takashi Kasugai, Kunio J Clin Biochem Nutr Original Article TANK-binding kinase 1 (TBK1) regulates the interferon regulatory factor (IRF) 3 and IRF7 activation pathways by double strand RNA (dsRNA) via Toll-like receptor (TLR) 3 and by lipopolysaccharide (LPS) via TLR4. Rebamipide is useful for treating inflammatory bowel disease (IBD). Although IBD is associated with nuclear factor-κB (NF-κB), any association with the TBK1-IRF pathway remains unknown. How rebamipide affects the TBK1-IRF pathway is also unclear. We analyzed the relationship between IBD (particularly ulcerative colitis; UC) and the TLR-TBK1-IRF3/7 pathway using human colon tissue, a murine model of colitis and human colonic epithelial cells. Inflamed colonic mucosa over-expressed TKB1, NAP1, IRF3, and IRF7 mRNA compared with normal mucosa. TBK1 was mainly expressed in inflammatory epithelial cells of UC patients. The expression of TBK1, IRF3, IRF7, IFN-α and IFN-β mRNA was suppressed in mice given oral dextran sulfate-sodium (DSS) and daily rectal rebamipide compared with mice given only DSS. Rebamipide reduced the expression of TBK1, IRF3 and IRF7 mRNA induced by LPS/dsRNA, but not of NF-κB mRNA in colonic epithelial cells. Rebamipide might suppress the TLR-TBK1 pathway, resulting in IRF3/7-induction of IFN-α/β and inflammatory factors. TBK1 is important in the induction of inflammation in patients with UC. If rebamipide represses the TLR-TBK1 pathway, then rectal administration should suppress inflammation of the colonic mucosa in patients with UC. the Society for Free Radical Research Japan 2011-03 2011-02-26 /pmc/articles/PMC3045689/ /pubmed/21373269 http://dx.doi.org/10.3164/jcbn.10-69 Text en Copyright © 2011 JCBN This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ogasawara, Naotaka Sasaki, Makoto Itoh, Yukimi Tokudome, Kentaro Kondo, Yoshihiro Ito, Yoshitsugi Tanida, Satoshi Kamiya, Takeshi Kataoka, Hiromi Joh, Takashi Kasugai, Kunio Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title | Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title_full | Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title_fullStr | Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title_full_unstemmed | Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title_short | Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction |
title_sort | rebamipide suppresses tlr-tbk1 signaling pathway resulting in regulating irf3/7 and ifn-α/β reduction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045689/ https://www.ncbi.nlm.nih.gov/pubmed/21373269 http://dx.doi.org/10.3164/jcbn.10-69 |
work_keys_str_mv | AT ogasawaranaotaka rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT sasakimakoto rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT itohyukimi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT tokudomekentaro rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT kondoyoshihiro rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT itoyoshitsugi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT tanidasatoshi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT kamiyatakeshi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT kataokahiromi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT johtakashi rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction AT kasugaikunio rebamipidesuppressestlrtbk1signalingpathwayresultinginregulatingirf37andifnabreduction |